89bio Inc (ETNB) Directors and Executive Officers - CSIMarket
CSIMarket
 
89bio Inc   (NASDAQ: ETNB)

89bio Inc

Officers & Directors


Edward Morrow Atkinson III
Director

Ryan Martins
Chief Financial Officer (principal financial and accounting officer)

Steven Altschuler
Director

Lota Zoth
Director

Derek DiRocco
Director


Auditor

Michael Hayden
Director

Kathleen D. LaPorte
Director

Rohan Palekar
Chief Executive Officer and Director (principal executive officer) ,

89bio Inc currently has 19 employees.

  News about 89bio Inc Key Personnel

89bio Provides Business Update and Outlook for 2025

89bio Inc.: Strategic Moves Amidst Financial Challenges and Promising Clinical DevelopmentsOverview of Recent Developments 89bio Inc. has been capturing attention in the biotechnology sector as it navigates a challenging financial landscape while making strides in clinical research and talent acquisition. The company recently provided a business update and a fresh outlook for 2025, signaling its commitment to developing therapies for severe hypertriglyceridemia (SHTG). Key developments include the completion of patient enrollment in the pivotal Phase 3 ENTRUST trial, with topline data anticipated in the latter half of 2025. However, this optimistic clinical progress comes amid significant financial strains...

89bio, Inc. Ramps Up Capital with $125 Million Public Offering Amid Financial Struggles

San Francisco, CA – November 12, 2024 – In a strategic move to bolster its financial standing, clinical-stage biopharmaceutical company 89bio, Inc. (Nasdaq: ETNB) has announced the pricing of an upsized public offering of common stock amounting to $125 million. This announcement comes on the heels of the company’s cumulative net loss of $175 million over the past year, marking a troubling negative return on investment of -33.56%.The offered shares, totaling 11,455,882, will be sold at a public offering price of $8.50 each. In a unique arrangement designed to accommodate certain investors, the company will also offer pre-funded warrants, allowing the purchase of up to 3,250,000 additional shares at a sl...






ETNB Management Effectiveness ETNB Revenue per Employee ETNB Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.